KP1019 (FFC14A) from bench to bedside: preclinical and early clinical development--an overview.

Authors :: Jakupec MA
Arion VB
Kapitza S
Reisner E
Eichinger A
Pongratz M
Marian B
Graf von Keyserlingk N
Keppler BK
Source :: International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2005 Dec; Vol. 43 (12), pp. 595-6.
Publication Year :: 2005

Subjects :: Animals
Antineoplastic Agents adverse effects
Antineoplastic Agents pharmacokinetics
Apoptosis
Cell Line, Tumor
Clinical Trials, Phase I as Topic
Drug Evaluation, Preclinical
Humans
Indazoles adverse effects
Indazoles pharmacokinetics
Organometallic Compounds
Oxidation-Reduction
Ruthenium Compounds adverse effects
Ruthenium Compounds pharmacokinetics
Transferrin metabolism
Antineoplastic Agents pharmacology
Indazoles pharmacology
Ruthenium Compounds pharmacology

Full Text Access

Tools